Amid Zolgensma crisis, Novartis gets a gene therapy boost as NICE embraces Luxturna
Top 10 gene therapy companies in 2019
Sangamo backs up early success for hemophilia gene therapy
Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! With the first gene therapy for blindness in the market, the door has been opened for a new wave of gene therapy treatments with the potential to cure genetic blindness. In December 2017, the FDA approved Luxturna, the first … Συνεχίστε να διαβάζετε Can Gene Therapy Become The Cure For Blindness?.
The gene therapy era has arrived. So have the challenges.
Roche outbid competing biopharma to secure Spark deal
In gene editing milestone, first patient treated in Vertex, CRISPR Therapeutics study
Roche Makes $4.8 Billion Bid for Spark Therapeutics and Its Gene Therapy Programs
Novo Nordisk nabs FDA nod for hemophilia A drug Esperoct but can’t launch until 2020
Johnson & Johnson dips a toe into gene therapy